HCM - Hutchison China MediTech Limited

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 53.24B
Enterprise value 32.91B
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)15.82
Price/book (mrq)9.97
Enterprise value/revenue 314.23
Enterprise value/EBITDA 6-22.84

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 33.86%
S&P500 52-week change 324.80%
52-week high 332.55
52-week low 316.47
50-day moving average 325.54
200-day moving average 321.95

Share statistics

Avg vol (3-month) 3226.89k
Avg vol (10-day) 3498.37k
Shares outstanding 5133.38M
Float 52.23M
% held by insiders 16.81%
% held by institutions 130.43%
Shares short (30 Dec 2019) 41.63M
Short ratio (30 Dec 2019) 49.37
Short % of float (30 Dec 2019) 4N/A
Short % of shares outstanding (30 Dec 2019) 41.22%
Shares short (prior month 28 Nov 2019) 41.42M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1
Last split date 329 May 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2018
Most-recent quarter (mrq)29 Sep 2019

Profitability

Profit margin -45.44%
Operating margin (ttm)-64.56%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)204.65M
Revenue per share (ttm)1.54
Quarterly revenue growth (yoy)-16.10%
Gross profit (ttm)-44M
EBITDA -127.46M
Net income avi to common (ttm)-93M
Diluted EPS (ttm)-0.70
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)201.58M
Total cash per share (mrq)1.51
Total debt (mrq)7.58M
Total debt/equity (mrq)2.24
Current ratio (mrq)2.63
Book value per share (mrq)2.36

Cash flow statement

Operating cash flow (ttm)-77.46M
Levered free cash flow (ttm)N/A